Novo Nordisk Forecast, price target & analysts
Novo Nordisk Target price 2026 - Analyst rating & recommendation
Novo Nordisk Classifications & Recommendation
Novo Nordisk Price Target
| Target Price | kr316.20 |
| Price | kr253.00 |
| Potential |
24.98%
register free of charge
|
| Number of Estimates | 31 |
|
31 Analysts have issued a price target Novo Nordisk 2027 .
The average Novo Nordisk target price is kr316.20.
This is
24.98%
register free of charge
kr479.85
89.66%
register free of charge
kr205.03
18.96%
register free of charge
|
|
| A rating was issued by 36 analysts: 11 Analysts recommend Novo Nordisk to buy, 22 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2027 of
24.98%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 309.06 | 305.40 |
| 6.43% | 1.19% | |
| EBITDA Margin | 48.42% | 48.48% |
| 1.15% | 0.13% | |
| Net Margin | 33.14% | 33.03% |
| 4.69% | 0.34% |
31 Analysts have issued a sales forecast Novo Nordisk 2026 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Novo Nordisk EBITDA forecast 2026. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Novo Nordisk Analysts have issued a net profit forecast 2026. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 23.03 | 22.79 |
| 1.77% | 1.04% | |
| P/E | 11.10 | |
| EV/Sales | 3.98 |
30 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Current Novo Nordisk Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JYSKE BANK |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JYSKE BANK:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 21 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
